DrugInformer Search

Fluphenazine Hydrochloride

Average User Review Score
* Based on 0 reviews from across the web.

Fluphenazine, sold under the brand names Prolixin among others, is a antipsychotic medication. It is used in the treatment of chronic psychoses such as schizophrenia. It is given by mouth, injection into a muscle, or just under the skin. There is a long acting injectable version that may last for up to four weeks.

Read more on Wikipedia

  Please use Workbench for in-depth research on Fluphenazine Hydrochloride.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Fluphenazine Hydrochloride

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: None

Posted By JonnieP in drugs.com on March 5, 2005 @ 12:00 am

Imprint Code: M4 Drug/Strength/Manufacturer: Fluphenazine Hydrochloride 1mg - Heartland Description: Tablet Coated MAYBE THIS IS IT. -JON

Druginformer Identified Side Effects: None

Posted By kirby in drugs.com on June 20, 2004 @ 12:00 am

M 97 is 10 mg fluphenazine hydrochloride. It's an antipsychotic medication. More info: http://fluphenazine.drugs.com/

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.